Albania vs Bahamas: HIV/AIDS deaths averted by antiretroviral therapy
Albania
51.15 deaths
in 2024
Bahamas
60.36 deaths
in 2024
Albania rank
135th
Bahamas rank
133rd
HIV/AIDS deaths averted by antiretroviral therapy over time
- Albania
- Bahamas
How they compare
Bahamas currently reports 60.36 deaths against 51.15 deaths in Albania, a difference of 9.21 deaths.
That makes Bahamas's figure about 1.2 times Albania's.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Bahamas ahead.
Albania ranks 135th and Bahamas ranks 133rd of 157 countries.
Bahamas has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Albania | Bahamas | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 4.99 deaths | 113.16 deaths | 108.17 deaths | Bahamas |
| 2010s | 35.4 deaths | 136.56 deaths | 101.17 deaths | Bahamas |
| 2020s | 48.41 deaths | 90.13 deaths | 41.72 deaths | Bahamas |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Albania or Bahamas?
- Bahamas, at 60.36 deaths against 51.15 deaths in Albania as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Albania and Bahamas?
- 9.21 deaths, with Bahamas ahead.
- How many years of comparable data are there for Albania and Bahamas?
- 35 years are reported by both, from 1990 to 2024.
- How do Albania and Bahamas rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Albania ranks 135th and Bahamas ranks 133rd of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.